Yoshimitsu Kobayashi

Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP.

K. Hatanaka, T. Miyagishima, K. Oba, 2015, Future oncology.

Phase II study of combined chemotherapy with irinotecan and S-1 ( IRIS ) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer Running title : IRIS plus bevacizumab for advanced colorectal cancer

K. Hatanaka, T. Miyagishima, Y. Sakata, 2017 .

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

K. Hatanaka, T. Miyagishima, Y. Sakata, 2012, Acta oncologica.

Multicenter Cohort Study to Assess the Association between Changes on Imaging and Outcome after Regorafenib Treatment (KSCC1603)

E. Oki, A. Nishie, H. Saeki, 2020, Oncology.

Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer

K. Hatanaka, T. Miyagishima, Y. Sakata, 2017, BMC Cancer.

Feasibility Study of Bolus 5-Fluorouracil+L-Leucovorin as Salvage Line Chemotherapy for Oral Fluorouracil-Resistant Unresectable Gastric Cancer: Hokkaido Gastrointestinal Cancer Study Group Study HGCSG1502

K. Hatanaka, T. Miyagishima, Y. Sakata, 2017 .